Aims and Scope of International Journal of Neuropsychopharmacology
The International Journal of Neuropsychopharmacology is a peer-reviewed scientific journal published by Oxford University Press. It is an official journal of the Collegium Internationale Neuro-Psychopharmacologicum (CINP) (International College of Neuro-Psychopharmacology) and covers basic and clinical topics in neuropharmacology and psychopharmacology. It was established in 1998 by Bernard Lerer, who served as editor-in-chief until 2008. Less
Key Metrics
CiteScore 

9.1
H-Index 

119
Impact Factor 

< 5
SJR 

Q1Pharmacology

SNIP 

1.45
Recommended pre-submission checks
Powered by 

Topics Covered on International Journal of Neuropsychopharmacology
International Journal of Neuropsychopharmacology Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | OXFORD UNIV PRESS |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | GBP 1945 |
| Publication Time | 12 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Collegium Internationale Neuro-Psychopharmacologicum (CINP) |
| Frequency | Monthly |
| Publication Start Year | 1998 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in International Journal of Neuropsychopharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in International Journal of Neuropsychopharmacology
Negative allosteric modulator of the metabotropic glutamate receptor 7 (mGlu7) ADX71743 increases wakefulness, reduces sleep and alters stress-induced changes in the brain neurotransmitter levels.
- 11 May 2026
- The international journal of neuropsychopharmacology
Trials, Trips, and Tribulations: Pathways for Implementing Psychedelic therapy in Ireland.
- 11 May 2026
- The international journal of neuropsychopharmacology
Life Engagement Improvements with Cariprazine in Schizophrenia: A Post-Hoc Analysis of PANSS Data from Short-Term Studies.
- 8 May 2026
- The international journal of neuropsychopharmacology
Late-onset major depression and subthreshold depressive symptoms as early clinical correlates of brain small vessel disease.
- 8 May 2026
- The international journal of neuropsychopharmacology
The introduction of measurement-based care for patients with schizophrenia may improve psychiatric symptoms and guideline adherence rate.
- 8 May 2026
- The international journal of neuropsychopharmacology
Heterogeneity in adverse events associated with lumateperone: a study on potential subgroup-specific differences.
- 8 May 2026
- The international journal of neuropsychopharmacology
Negative allosteric modulator of the metabotropic glutamate receptor 7 (mGlu7) ADX71743 increases wakefulness, reduces sleep and alters stress-induced changes in the brain neurotransmitter levels.
- 11 May 2026
- The international journal of neuropsychopharmacology
Trials, Trips, and Tribulations: Pathways for Implementing Psychedelic therapy in Ireland.
- 11 May 2026
- The international journal of neuropsychopharmacology
Life Engagement Improvements with Cariprazine in Schizophrenia: A Post-Hoc Analysis of PANSS Data from Short-Term Studies.
- 8 May 2026
- The international journal of neuropsychopharmacology
Late-onset major depression and subthreshold depressive symptoms as early clinical correlates of brain small vessel disease.
- 8 May 2026
- The international journal of neuropsychopharmacology
The introduction of measurement-based care for patients with schizophrenia may improve psychiatric symptoms and guideline adherence rate.
- 8 May 2026
- The international journal of neuropsychopharmacology
Heterogeneity in adverse events associated with lumateperone: a study on potential subgroup-specific differences.
- 8 May 2026
- The international journal of neuropsychopharmacology